0001104659-24-034035.txt : 20240313 0001104659-24-034035.hdr.sgml : 20240313 20240313181023 ACCESSION NUMBER: 0001104659-24-034035 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240311 FILED AS OF DATE: 20240313 DATE AS OF CHANGE: 20240313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROBERTSON MICHELLE CENTRAL INDEX KEY: 0001755098 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35403 FILM NUMBER: 24747286 MAIL ADDRESS: STREET 1: C/O MOMENTA PHARMACEUTICALS, INC. STREET 2: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Verastem, Inc. CENTRAL INDEX KEY: 0001526119 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 273269467 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 117 KENDRICK STREET STREET 2: SUITE 500 CITY: NEEDHAM STATE: MA ZIP: 02494 BUSINESS PHONE: (781) 292-4200 MAIL ADDRESS: STREET 1: 117 KENDRICK STREET STREET 2: SUITE 500 CITY: NEEDHAM STATE: MA ZIP: 02494 4 1 tm248737-2_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-03-11 0 0001526119 Verastem, Inc. VSTM 0001755098 ROBERTSON MICHELLE C/O VERASTEM, INC., 117 KENDRICK ST., SUITE 500 NEEDHAM MA 02494 1 0 0 0 0 Stock Option (right to buy) 37.32 2024-03-11 4 D 0 5291 D 2031-11-15 Common Stock 5291 0 D Stock Option (right to buy) 11.44 2024-03-11 4 A 0 5291 A 2034-03-11 Common Stock 5291 5291 D On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 5,291 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date. The canceled stock option was granted on November 15, 2021 and provided for vesting in twelve equal month installments beginning on the on the last day of each month over a period from November 2021 to October 2022. /s/ Daniel Calkins, Attorney in Fact 2024-03-13